Autoimmune Lymphoproliferative Syndrome (ALPS)

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|9|3|265-278

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.9, Iss.3, 2003-01, pp. : 265-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Autoimmune Lymphoproliferative Syndrome: Etiology, Diagnosis, and Management

By van der Werff ten Bosch J.  

Pediatric Drugs, Vol. 5, Iss. 3, 2003-01 ,pp. : 185-193

Adis International

Access to resources Recommend Favorite

Ofatumumab, a second-generation anti-CD20 monoclonal antibody, for the treatment of lymphoproliferative and autoimmune disorders

By Castillo Jorge   Milani Cannon   Mendez-Allwood Daniel  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 491-500

Informa Healthcare

Access to resources Recommend Favorite

Thiamazole: Insulin autoimmune syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1436, 2013-01 ,pp. : 32-32

Adis International

Access to resources Recommend Favorite

Infliximab: Lupus-like syndrome and autoimmune hepatitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1206, 2008-01 ,pp. : 18-19

Adis International

Access to resources Recommend Favorite

Minocycline: Drug hypersensitivity syndrome followed by multiple autoimmune sequelae: case report

By  

Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite